Results overview: Found 6 records in 0.03 seconds.
Articles, 6 records found
Articles 6 records found  
1.
13 p, 1.1 MB Cord Blood Cardiovascular Biomarkers in Left-Sided Congenital Heart Disease / Soveral, Iris (Hospital Clínic i Provincial de Barcelona) ; Guirado, Laura (Hospital Clínic i Provincial de Barcelona) ; Escobar-Diaz, Maria C. (Sant Joan de Déu Hospital) ; Alcaide, María José (Hospital Universitario La Paz (Madrid)) ; Martínez, Josep Maria (Hospital Clínic i Provincial de Barcelona) ; Rodríguez Sureda, Víctor (Hospital Clínic i Provincial de Barcelona) ; Bijnens, Bart (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Antolin, Eugenia (Hospital Universitario La Paz (Madrid)) ; Llurba, E (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Bartha, José Luis (Hospital Universitario La Paz (Madrid)) ; Gómez, Olga (Hospital Clínic i Provincial de Barcelona) ; Crispi, Fatima (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
Fetal echocardiography has limited prognostic ability in the evaluation of left-sided congenital heart defects (left heart defects). Cord blood cardiovascular biomarkers could improve the prognostic evaluation of left heart defects. [...]
2022 - 10.3390/jcm11237119
Journal of clinical medicine, Vol. 11 (november 2022)  
2.
8 p, 1.1 MB A pilot study of circulating levels of TGF-β1 and TGF-β2 as biomarkers of bone healing in patients with non-hypertrophic pseudoarthrosis of long bones / Chaverri, Daniel (Hospital ASEPEYO Sant Cugat) ; Vivas, Daniel (Banc de Sang i Teixits) ; Gallardo-Villares, Santiago (Hospital ASEPEYO Sant Cugat) ; Granell-Escobar, Fernando (Hospital ASEPEYO Sant Cugat) ; Pinto, Javier A. (Hospital ASEPEYO Sant Cugat) ; Vives Armengol, Joaquim (Universitat Autònoma de Barcelona. Departament de Medicina)
Pseudoarthrosis or non-union is a complication with an incidence of 5-10% of bone fractures, most frequently located in the diaphysis of long bones. The management of this complication is addressed by means of complex surgical procedures and is a concern for orthopaedic and trauma surgeons nowadays. [...]
2021 - 10.1016/j.bonr.2021.101157
Bone Reports, Vol. 16 (december 2021)  
3.
18 p, 2.6 MB Partial remission and early stages of pediatric type 1 diabetes display immunoregulatory changes. A pilot study / Villalba Felipe, Adrián (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Fonolleda, Mireia (Institut Germans Trias i Pujol) ; Murillo-Vallés, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Rodríguez-Fernández, Silvia (Institut Germans Trias i Pujol) ; Ampudia Carrasco, Rosa María (Institut Germans Trias i Pujol) ; Perna-Barrull, David (Institut Germans Trias i Pujol) ; Raina, María Belén (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Quirant, Bibiana (Institut Germans Trias i Pujol) ; Planas, Raquel (Institut Germans Trias i Pujol) ; Teniente Serra, Aina (Institut Germans Trias i Pujol) ; Bel, Joan (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Vives Pi, Marta (Institut Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Type 1 diabetes (T1D) is a chronic metabolic disease of unknown etiology that results from β-cell destruction. The onset of the disease, which arises after a long asymptomatic period of autoimmune attack, may be followed by a relapsing and remitting progression, a phenomenon that is most evident during the partial remission phase (PR). [...]
2019 - 10.1016/j.trsl.2019.03.002
Translational Research, Vol. 210 (august 2019) , p. 8-25  
4.
36 p, 10.5 MB Defective AMH signaling disrupts GnRH neuron development and function and contributes to hypogonadotropic hypogonadism / Malone, Samuel Andrew (Jean-Pierre Aubert Research Center) ; Papadakis, Georgios E. (Lausanne University Hospital) ; Messina, Andrea (Lausanne University Hospital) ; Mimouni, Nour El Houda (Jean-Pierre Aubert Research Center) ; Trova, Sara (Jean-Pierre Aubert Research Center) ; Imbernon, Monica (Jean-Pierre Aubert Research Center) ; Allet, Cecile (Jean-Pierre Aubert Research Center) ; Cimino, Irene (Jean-Pierre Aubert Research Center) ; Acierno, James (Lausanne University Hospital) ; Cassatella, Daniele (Lausanne University Hospital) ; Xu, Cheng (Lausanne University Hospital) ; Quinton, Richard (University of Newcastle-upon-Tyne. Institute of Genetic Medicine) ; Szinnai, Gabor (University Children's Hospital Basel (Basilea, Suïssa)) ; Pigny, Pascal (Centre de Biologie Pathologie Génétique. Service Hormonologie Métabolisme Nutrition Oncologie) ; Alonso-Cotchico, Lur (Universitat Autònoma de Barcelona. Departament de Química) ; Masgrau, Laura (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Maréchal, Jean-Didier (Universitat Autònoma de Barcelona. Departament de Química) ; Prevot, V. (Jean-Pierre Aubert Research Center) ; Pitteloud, Nelly (Lausanne University Hospital) ; Giacobini, Polo (Jean-Pierre Aubert Research Center)
Congenital hypogonadotropic hypogonadism (CHH) is a condition characterized by absent puberty and infertility due to gonadotropin releasing hormone (GnRH) deficiency, which is often associated with anosmia (Kallmann syndrome, KS). [...]
2019 - 10.7554/eLife.47198
eLife, Vol. 8 (2019) , art. e47198  
5.
8 p, 500.8 KB Relative bioavailability of three formulations of galunisertib administered as monotherapy in patients with advanced or metastatic cancer / Gueorguieva, Ivelina (Eli Lilly and Company (United Kingdom)) ; Cleverly, Ann (Eli Lilly and Company (United Kingdom)) ; Desaiah, Durisala (Eli Lilly and Company (USA)) ; Azaro, Analía (Hospital Universitari Vall d'Hebron) ; Seoane Suárez, Joan (Vall d'Hebron Institut d'Oncologia) ; Braña, Irene (Hospital Universitari Vall d'Hebron) ; Sicart, Elisabet (Hospital Universitari Vall d'Hebron) ; Miles, Colin (Eli Lilly and Company (United Kingdom)) ; Lahn, Michael M.. (Eli Lilly and Company (USA)) ; Mitchell, Malcolm I (Eli Lilly and Company (USA)) ; Rodón Ahnert, Jordi (Vall d'Hebron Institut d'Oncologia) ; Universitat Autònoma de Barcelona
Galunisertib (LY2157299 monohydrate), an inhibitor of the transforming growth factor β (TGFβ) pathway, is currently under investigation in several clinical trials involving multiple tumor types. The primary objective of this study was to assess relative bioavailability of two new galunisertib formulations developed using the roller compaction (RC) dry-milled (RCD) and RC slurry-milled (RCS) processes, compared with the existing formulation developed using the high-sheer wet granulation (HSWG) process. [...]
2016 - 10.7573/dic.212303
Drugs in Context, Vol. 5 (December 2016) , art. 201303  
6.
10 p, 398.5 KB Effects of the breed, sex and age on cellular content and growth factor release from equine pure-platelet rich plasma and pure-platelet rich gel / Giraldo, Carlos E. (Universidad de Caldas. Departamento de Salud Animal (Manizales, Colòmbia)) ; López, Catalina (Universidad de Caldas. Departamento de Salud Animal (Manizales, Colòmbia)) ; Álvarez, María E. (Universidad de Caldas. Departamento de Salud Animal (Manizales, Colòmbia)) ; Samudio, Ismael J. (Pontificia Universidad Javeriana. Departamento de Nutrición y Bioquímica) ; Prades, Marta (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ; Carmona Ramírez, Jorge Uriel (Universidad de Caldas (Manizales, Colòmbia). Departamento de Salud Animal)
Background: There is no information on the effects of the breed, gender and age on the cellular content and growth factor (GF) release from equine pure-platelet rich plasma (P-PRP) and pure-platelet rich gel (P-PRG). [...]
2013 - 10.1186/1746-6148-9-29
BMC veterinary research, Vol. 9, Núm. 29 (February 2013) , p. 1-10  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.